Hi! 👋 We have a new venture. Please check out Satire Labs 😉.
The funniest way to turn your $100 to $1 million. ⛴️ 🚢.
Note: This is a joke. Kinda. We really do think you'll make money 😎🙂

  Alexion Pharmaceuticals Inc ( ALXN ) |
1995 - 2021 (27 years)

Net Revenue (Sales) is 
$6.2B (1Y +11.9% )

ALXN Stock Price & Net Revenue (Sales)

Net Revenue (Sales) for ALXN competitors.
CELG GILD REGN VRTX BIIB AGIO RARE IONS QGEN XON
Note: Stonk = Stock. Both words are used interchangeably. 🙂

Historical (All-Time) Stats for Net Revenue (Sales)

chevron_right 2021 $1.6B +3182x
( +34.8% / year avg)
chevron_left 1995 $500.0K
vertical_align_top Peak $5.9B +11723x
vertical_align_bottom Bottom $500.0K
arrow_drop_up # Up Years 19 19 of 27
years up.
arrow_drop_down # Down Years 8
Up Years = Positive (0%+) YoY change
Down Years = Zero or Negative (0% or less) YoY change

Key Points (Stonk Price Comparison)

  • ALXN's stock price has rallied +4,601% from $2.31 in 1995 , or +0.01x the rate relative to it's net revenue (sales) over the same period.
  • If ALXN grows it's stock at the same rate as it's net revenue (sales) (+34.8%/year) , it's stock price will grow +1,981% and hit $2153.81 over the next 10 years.
  • ALXN's stock price has gone up 0 of the 19 years (0%) it's net revenue (sales) were also up.
  • Line Item (in $M) FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999 FY 1998 FY 1997
    1 Revenue 6069900000.00 4991100000.00 4131200000.00 3551100000.00 3084000000.00 2604047000.00 2233733000.00 1551346000.00 1134114000.00 783431000.00 540957000.00 386800000.00 259099000.00 72041000.00 1558000.00 1064000.00 700000.00 1064000.00 700000.00 1064000.00 700000.00 1064000.00 700000.00 1064000.00 700000.00 1064000.00 700000.00 1064000.00 700000.00 1064000.00 700000.00 4609000.00 877000.00 6536000.00 11805000.00 21441000.00 18800000.00 5000000.00 3800000.00
    2 Cost of Revenue 553500000.00 394500000.00 374300000.00 454200000.00 258000000.00 233089000.00 173862000.00 177556000.00 72837000.00 93140000.00 64437000.00 45059000.00 28366000.00 6696000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    3 Gross Profit (Income) 5516400000.00 4596600000.00 3756900000.00 3096900000.00 2826000000.00 2370958000.00 2059871000.00 1373790000.00 1061277000.00 690291000.00 476520000.00 341741000.00 230733000.00 65345000.00 0.00 0.00 700000.00 0.00 700000.00 0.00 700000.00 0.00 700000.00 0.00 700000.00 0.00 700000.00 0.00 700000.00 0.00 700000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    4 R&D 1002900000.00 886000000.00 730400000.00 878400000.00 757000000.00 709472000.00 513782000.00 317093000.00 222732000.00 137421000.00 98394000.00 81915000.00 62581000.00 68961000.00 83225000.00 91388000.00 48200000.00 91388000.00 48200000.00 91388000.00 48200000.00 91388000.00 48200000.00 91388000.00 48200000.00 91388000.00 48200000.00 91388000.00 48200000.00 91388000.00 48200000.00 59840000.00 71042000.00 60005000.00 38871000.00 40187000.00 23700000.00 12300000.00 9100000.00
    5 SG&A 1399900000.00 1261100000.00 1111800000.00 1094400000.00 954000000.00 862595000.00 630209000.00 489720000.00 384678000.00 308176000.00 227488000.00 172767000.00 133543000.00 96142000.00 54879000.00 18951000.00 12800000.00 18951000.00 12800000.00 18951000.00 12800000.00 18951000.00 12800000.00 18951000.00 12800000.00 18951000.00 12800000.00 18951000.00 12800000.00 18951000.00 12800000.00 14459000.00 10621000.00 7993000.00 7135000.00 4175000.00 3000000.00 2700000.00 2800000.00
    6 Other Expenses -3300000.00 35900000.00 5500000.00 300000.00 0.00 0.00 3401000.00 -1741000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1931000.00 0.00 1931000.00 0.00 1931000.00 0.00 1931000.00 0.00 1931000.00 0.00 1931000.00 0.00 1931000.00 0.00 1931000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    7 Operating Expenses 2656500000.00 2456700000.00 2162300000.00 2292900000.00 2033000000.00 1688651000.00 1143991000.00 807230000.00 607827000.00 445979000.00 325882000.00 254682000.00 196124000.00 165103000.00 138643000.00 111403000.00 61000000.00 111403000.00 61000000.00 111403000.00 61000000.00 111403000.00 61000000.00 111403000.00 61000000.00 111403000.00 61000000.00 111403000.00 61000000.00 111403000.00 61000000.00 75059000.00 84223000.00 67998000.00 48907000.00 44362000.00 26700000.00 15000000.00 11900000.00
    8 Interest Expense 104700000.00 77800000.00 98200000.00 98400000.00 97000000.00 47744000.00 2982000.00 4112000.00 7402000.00 788000.00 704000.00 606000.00 2407000.00 0.00 0.00 0.00 1192000.00 0.00 1192000.00 0.00 1192000.00 0.00 1192000.00 0.00 1192000.00 0.00 1192000.00 0.00 1192000.00 0.00 1192000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    9 D&A 253700000.00 309600000.00 320100000.00 320100000.00 322000000.00 116584000.00 46939000.00 417000.00 417000.00 382000.00 15792000.00 12473000.00 7608000.00 4927000.00 3706000.00 3682000.00 1600000.00 3682000.00 1600000.00 3682000.00 1600000.00 3682000.00 1600000.00 3682000.00 1600000.00 3682000.00 1600000.00 3682000.00 1600000.00 3682000.00 1600000.00 3593000.00 3726000.00 3562000.00 2901000.00 1769000.00 900000.00 600000.00 700000.00
    10 EBITDA 3113600000.00 2449500000.00 1914700000.00 1124100000.00 1115000000.00 798891000.00 962819000.00 566977000.00 453867000.00 244694000.00 166430000.00 99532000.00 42217000.00 -94831000.00 -133379000.00 -106657000.00 -58700000.00 -106657000.00 -58700000.00 -106657000.00 -58700000.00 -106657000.00 -58700000.00 -106657000.00 -58700000.00 -106657000.00 -58700000.00 -106657000.00 -58700000.00 -106657000.00 -58700000.00 -66857000.00 -79620000.00 -57900000.00 -34201000.00 -21152000.00 -7000000.00 -9400000.00 -7400000.00
    11 Operating Income 2859900000.00 2139900000.00 1594600000.00 804000000.00 793000000.00 682307000.00 915880000.00 566560000.00 453450000.00 244312000.00 150638000.00 87059000.00 34609000.00 -99758000.00 -137085000.00 -110339000.00 -60300000.00 -110339000.00 -60300000.00 -110339000.00 -60300000.00 -110339000.00 -60300000.00 -110339000.00 -60300000.00 -110339000.00 -60300000.00 -110339000.00 -60300000.00 -110339000.00 -60300000.00 -70450000.00 -83346000.00 -61462000.00 -37102000.00 -22921000.00 -7900000.00 -10000000.00 -8100000.00
    12 Other Income Expenses (Net) -2186200000.00 116700000.00 -1254200000.00 -157800000.00 -120000000.00 -136421000.00 -40791000.00 -36179000.00 -48482000.00 -15767000.00 -2434000.00 -3139000.00 2528000.00 9212000.00 -580000.00 5885000.00 0.00 5885000.00 0.00 5885000.00 0.00 5885000.00 0.00 5885000.00 0.00 5885000.00 0.00 5885000.00 0.00 5885000.00 0.00 -760000.00 -2560000.00 0.00 -21000000.00 0.00 1500000.00 2100000.00 800000.00
    13 Pre-Income Tax 569000000.00 2178800000.00 242200000.00 547800000.00 576000000.00 498142000.00 872107000.00 526269000.00 397566000.00 229668000.00 149011000.00 83314000.00 34730000.00 -93035000.00 -131887000.00 -109515000.00 -58400000.00 -109515000.00 -58400000.00 -109515000.00 -58400000.00 -109515000.00 -58400000.00 -109515000.00 -58400000.00 -109515000.00 -58400000.00 -109515000.00 -58400000.00 -109515000.00 -58400000.00 -74786000.00 -85231000.00 -57242000.00 -47925000.00 0.00 0.00 0.00 0.00
    14 Income Tax Expense -34400000.00 -225500000.00 164600000.00 104500000.00 177000000.00 353757000.00 215195000.00 273374000.00 142744000.00 54353000.00 51981000.00 -211852000.00 1581000.00 -745000.00 -373000.00 -765000.00 -500000.00 -765000.00 -500000.00 -765000.00 -500000.00 -765000.00 -500000.00 -765000.00 -500000.00 -765000.00 -500000.00 -765000.00 -500000.00 -765000.00 -500000.00 -691000.00 -764000.00 -700000.00 0.00 0.00 0.00 0.00 0.00
    15 Net Income 603400000.00 2404300000.00 77600000.00 443300000.00 399000000.00 144385000.00 656912000.00 252895000.00 254822000.00 175315000.00 97030000.00 295166000.00 33149000.00 -92290000.00 -131514000.00 -108750000.00 -58000000.00 -108750000.00 -58000000.00 -108750000.00 -58000000.00 -108750000.00 -58000000.00 -108750000.00 -58000000.00 -108750000.00 -58000000.00 -108750000.00 -58000000.00 -108750000.00 -58000000.00 -74095000.00 -84467000.00 -56542000.00 -57043000.00 -20227000.00 -6400000.00 -7900000.00 -7300000.00
    16 EPS 2.74 10.77 0.35 1.98 1.78 0.68 3.32 1.29 1.34 0.96 0.55 1.73 0.21 -0.64 -1.04 -0.97 -0.48 -0.97 -0.48 -0.97 -0.48 -0.97 -0.48 -0.97 -0.48 -0.97 -0.48 -0.97 -0.48 -0.97 -0.48 -0.86 -1.16 -0.78 -0.82 -0.36 -0.14 -0.22 -0.24
    17 EPS Diluted 2.72 10.70 0.35 1.97 1.76 0.67 3.26 1.27 1.28 0.91 0.52 1.63 0.20 -0.64 -1.04 -0.97 -0.48 -0.97 -0.48 -0.97 -0.48 -0.97 -0.48 -0.97 -0.48 -0.97 -0.48 -0.97 -0.48 -0.97 -0.48 -0.86 -1.16 -0.78 -0.82 -0.36 -0.14 -0.22 -0.24
    18 Shares Outstanding 219100000 223200000 222700000 223900000 224000000 213431000 198103000 195532000 190461000 183220000 178542000 170652000 155360000 145244000 126804000 111408000 122100000 111408000 122100000 111408000 122100000 111408000 122100000 111408000 122100000 111408000 122100000 111408000 122100000 111408000 122100000 86488000 72836000 72584000 69484000 55656000 45060000 40225356 29803048
    19 Shares Outstanding (Diluted) 219100000 224800000 224500000 225400000 227000000 215933000 201623000 199712000 198501000 191806000 186074000 181164000 179934000 145244000 126804000 111408000 122100000 111408000 122100000 111408000 122100000 111408000 122100000 111408000 122100000 111408000 122100000 111408000 122100000 111408000 122100000 86488000 72836000 72584000 69484000 55656000 45060000 40225356 29803048
  • Line Item (in $M) FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999 FY 1998 FY 1997
    1 Cash & Cash Equivalents 2964500000.00 2685500000.00 1365500000.00 584400000.00 966000000.00 1010111000.00 943999000.00 529857000.00 989501000.00 540865000.00 267145000.00 157172000.00 138012000.00 95321000.00 166826000.00 46951000.00 43629000.00 46951000.00 43629000.00 46951000.00 43629000.00 46951000.00 43629000.00 46951000.00 43629000.00 46951000.00 43629000.00 46951000.00 43629000.00 46951000.00 43629000.00 113224000.00 24844000.00 47574000.00 135188000.00 91858000.00 24200000.00 31500000.00 16700000.00
    2 Short Term Investments 34900000.00 64000000.00 198300000.00 889700000.00 327000000.00 374904000.00 1017567000.00 984994000.00 0.00 0.00 94460000.00 19048000.00 0.00 10433000.00 49728000.00 148453000.00 168827000.00 148453000.00 168827000.00 148453000.00 168827000.00 148453000.00 168827000.00 148453000.00 168827000.00 148453000.00 168827000.00 148453000.00 168827000.00 148453000.00 168827000.00 153277000.00 190566000.00 261010000.00 220086000.00 82671000.00 4100000.00 6000000.00 6000000.00
    3 Cash & S-T Investments 2999400000.00 2749500000.00 1563800000.00 1474100000.00 1293000000.00 1385015000.00 1961566000.00 1514851000.00 989501000.00 540865000.00 361605000.00 176220000.00 138012000.00 105754000.00 216554000.00 195404000.00 212456000.00 195404000.00 212456000.00 195404000.00 212456000.00 195404000.00 212456000.00 195404000.00 212456000.00 195404000.00 212456000.00 195404000.00 212456000.00 195404000.00 212456000.00 266501000.00 215410000.00 308584000.00 355274000.00 174529000.00 28300000.00 37500000.00 22700000.00
    4 Accounts Receivables 1409300000.00 1243200000.00 922300000.00 726500000.00 650000000.00 532832000.00 432888000.00 421752000.00 295598000.00 244288000.00 168732000.00 113731000.00 74476000.00 49647000.00 1642000.00 1316000.00 0.00 1316000.00 0.00 1316000.00 0.00 1316000.00 0.00 1316000.00 0.00 1316000.00 0.00 1316000.00 0.00 1316000.00 0.00 5493000.00 1012000.00 0.00 0.00 0.00 6900000.00 0.00 0.00
    5 Inventory 775700000.00 627600000.00 472500000.00 460400000.00 375000000.00 289874000.00 176441000.00 102602000.00 94521000.00 81386000.00 62165000.00 40885000.00 49821000.00 32907000.00 2314000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    6 Other Current Assets 651000000.00 0.00 0.00 0.00 0.00 0.00 189401000.00 35243000.00 31493000.00 596464000.00 0.00 204175000.00 0.00 3271000.00 0.00 139000.00 0.00 139000.00 0.00 139000.00 0.00 139000.00 0.00 139000.00 0.00 139000.00 0.00 139000.00 0.00 139000.00 0.00 826000.00 390000.00 863000.00 6980000.00 5551000.00 0.00 100000.00 100000.00
    7 Total Current Assets 5833000000 5076400000 3385000000 2953900000 2578000000 2425349000 2796029000 2186857000 1495600000 941270000 646556000 373456000 277101000 205354000 222841000 201162000 217551000 201162000 217551000 201162000 217551000 201162000 217551000 201162000 217551000 201162000 217551000 201162000 217551000 201162000 217551000 276333000 219760000 310784000 362747000 180080000 35700000 37800000 23000000
    8 PP&E 1461900000.00 1163000000.00 1471000000.00 1325000000.00 1036000000.00 697025000.00 392248000.00 201109000.00 165629000.00 165852000.00 162240000.00 164691000.00 139885000.00 104280000.00 39135000.00 11546000.00 10631000.00 11546000.00 10631000.00 11546000.00 10631000.00 11546000.00 10631000.00 11546000.00 10631000.00 11546000.00 10631000.00 11546000.00 10631000.00 11546000.00 10631000.00 11336000.00 12276000.00 14874000.00 13731000.00 8213000.00 7400000.00 2400000.00 800000.00
    9 Goodwill 5100100000.00 5037400000.00 5037400000.00 5037400000.00 5037000000.00 5047885000.00 254073000.00 254073000.00 253645000.00 79639000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    10 Intangible Assets 3002400000.00 3344300000.00 3641300000.00 3954400000.00 4303000000.00 4707914000.00 587046000.00 609719000.00 646678000.00 91604000.00 24146000.00 28589000.00 32325000.00 0.00 0.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 20270000.00 0.00 0.00 300000.00 400000.00
    11 Goodwill & Intangible Assets 8102500000.00 8381700000.00 8678700000.00 8991800000.00 9340000000.00 9755799000.00 841119000.00 863792000.00 900323000.00 171243000.00 44100000.00 48543000.00 52279000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 19954000.00 20270000.00 0.00 0.00 300000.00 400000.00
    12 L-T Investments 34000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    13 Tax Assets 2199400000.00 2290200000.00 0.00 0.00 0.00 0.00 34939000.00 3394000.00 13954000.00 103868000.00 154569000.00 194308000.00 3397000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    14 Other Non-Current Assets 506200000.00 429000000.00 396700000.00 312200000.00 299000000.00 255057000.00 137627000.00 62544000.00 38054000.00 12518000.00 4572000.00 5403000.00 4889000.00 4769000.00 51607000.00 15460000.00 14575000.00 15460000.00 14575000.00 15460000.00 14575000.00 15460000.00 14575000.00 15460000.00 14575000.00 15460000.00 14575000.00 15460000.00 14575000.00 15460000.00 14575000.00 11922000.00 14087000.00 8457000.00 3511000.00 4409000.00 1300000.00 1600000.00 100000.00
    15 Total Non-Current Assets 12270000000.00 12468200000.00 10546900000.00 10629400000.00 10675000000.00 10707881000.00 1405933000.00 1130839000.00 1117960000.00 453481000.00 365481000.00 412945000.00 200450000.00 129003000.00 110696000.00 46960000.00 45160000.00 46960000.00 45160000.00 46960000.00 45160000.00 46960000.00 45160000.00 46960000.00 45160000.00 46960000.00 45160000.00 46960000.00 45160000.00 46960000.00 45160000.00 43242000.00 46317000.00 43285000.00 37512000.00 12622000.00 8700000.00 4300000.00 1300000.00
    16 Other Assets 2896000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    17 Total Assets 18103000000 17544600000 13931900000 13583300000 13253000000 13133230000 4201962000 3317696000 2613560000 1394751000 1012037000 786401000 477551000 334357000 333537000 248122000 262711000 248122000 262711000 248122000 262711000 248122000 262711000 248122000 262711000 248122000 262711000 248122000 262711000 248122000 262711000 319575000 266077000 354069000 400259000 192702000 44400000 42100000 24300000
    18 Accounts Payables 118600000.00 74000000.00 74400000.00 70800000.00 64000000.00 57360000.00 44016000.00 21596000.00 21488000.00 16029000.00 16026000.00 11530000.00 8655000.00 9072000.00 10939000.00 7455000.00 3865000.00 7455000.00 3865000.00 7455000.00 3865000.00 7455000.00 3865000.00 7455000.00 3865000.00 7455000.00 3865000.00 7455000.00 3865000.00 7455000.00 3865000.00 8298000.00 7560000.00 9843000.00 1722000.00 2100000.00 3500000.00 800000.00 700000.00
    19 S-T Debt 142400000.00 126700000.00 343800000.00 167400000.00 167000000.00 175000000.00 48000000.00 48000000.00 48000000.00 718000.00 0.00 0.00 2500000.00 272000.00 67000.00 75000.00 129000.00 75000.00 129000.00 75000.00 129000.00 75000.00 129000.00 75000.00 129000.00 75000.00 129000.00 75000.00 129000.00 75000.00 129000.00 3920000.00 0.00 0.00 0.00 369000.00 400000.00 400000.00 100000.00
    20 Income Tax Payables 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    21 Deferred Revenue 0.00 0.00 0.00 15900000.00 37000000.00 20504000.00 58837000.00 53801000.00 31266000.00 18767000.00 2896000.00 1652000.00 1128000.00 41000.00 588000.00 820000.00 767000.00 820000.00 767000.00 820000.00 767000.00 820000.00 767000.00 820000.00 767000.00 820000.00 767000.00 820000.00 767000.00 820000.00 767000.00 588000.00 589000.00 546000.00 1351000.00 0.00 500000.00 100000.00 300000.00
    22 Other Current Liabilities 279000000.00 100900000.00 132000000.00 59000000.00 47000000.00 62038000.00 60655000.00 56688000.00 9548000.00 32469000.00 11848000.00 2155000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 188000.00 0.00 0.00 2646000.00 4709000.00 0.00 0.00 100000.00
    23 Total Current Liabilities 1624700000.00 1194300000.00 1174000000.00 952500000.00 823000000.00 718250000.00 606740000.00 582429000.00 360089000.00 230225000.00 138515000.00 85262000.00 84418000.00 37709000.00 27822000.00 24714000.00 25390000.00 24714000.00 25390000.00 24714000.00 25390000.00 24714000.00 25390000.00 24714000.00 25390000.00 24714000.00 25390000.00 24714000.00 25390000.00 24714000.00 25390000.00 19673000.00 15107000.00 17319000.00 7990000.00 7178000.00 6700000.00 2100000.00 2400000.00
    24 L-T Debt 2419600000.00 2375000000.00 2501700000.00 2720700000.00 2888000000.00 3281250000.00 9500000.00 65000000.00 101000000.00 0.00 3718000.00 9918000.00 141222000.00 194000000.00 176000000.00 150000000.00 150000000.00 150000000.00 150000000.00 150000000.00 150000000.00 150000000.00 150000000.00 150000000.00 150000000.00 150000000.00 150000000.00 150000000.00 150000000.00 150000000.00 150000000.00 120000000.00 123920000.00 123920000.00 123920000.00 123920000.00 4400000.00 800000.00 0.00
  • Line Item (in $M) FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999 FY 1998 FY 1997
    1 Net Income (Earnings) 603400000 2404300000 77600000 443300000 399000000 144385000 656912000 252895000 254822000 175315000 97030000 295166000 33149000 -92290000 -131514000 -108750000 -58000000 -108750000 -58000000 -108750000 -58000000 -108750000 -58000000 -108750000 -58000000 -108750000 -58000000 -108750000 -58000000 -108750000 -58000000 -74095000 -84467000 -56542000 -57043000 -20227000 -6400000 -7900000 -7300000
    2 D&A 329400000 376800000 405300000 496700000 396000000 166621000 46939000 28693000 23887000 17616000 15792000 12473000 7608000 4927000 3706000 3682000 1600000 3682000 1600000 3682000 1600000 3682000 1600000 3682000 1600000 3682000 1600000 3682000 1600000 3682000 1600000 3593000 3726000 3562000 5521000 1769000 900000 600000 700000
    3 Deferred Income Tax -283400000 -455400000 32900000 -45900000 104000000 395495000 -153905000 92831000 71155000 42066000 36389000 -208726000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
    4 Stock-Based Compensation (SBC) 281100000 237000000 203000000 243100000 192000000 227133000 114461000 76203000 54013000 44763000 32338000 28731000 23682000 0 0 0 4314000 0 4314000 0 4314000 0 4314000 0 4314000 0 4314000 0 4314000 0 4314000 0 0 0 0 0 0 0 0
    5 Change in Working Capital 326200000 1671100000 209600000 246400000 47901000 -482190000 584861000 468917000 424466000 203004000 219847000 95511000 25038000 -27374000 2858000 -80212000 15713000 -80212000 15713000 -80212000 15713000 -80212000 15713000 -80212000 15713000 -80212000 15713000 -80212000 15713000 -80212000 15713000 52007000 -88812000 -61292000 181855000 143902000 -6700000 15100000 3500000
    6 Accounts Receivables -139400000 -319200000 -208800000 -55200000 -122000000 -115812000 -28137000 -116439000 -72870000 -78778000 -59239000 -36440000 -31262000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
    7 Inventory 95000000 -156900000 -14700000 -88200000 -84000000 -88375000 -66812000 126000 -6265000 -12179000 -14119000 14596000 -15700000 -30593000 -2314000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
    8 Accounts Payables 122000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -3589000 0 -3589000 0 -3589000 0 -3589000 0 -3589000 0 -3589000 0 -3589000 0 -3589000 0 0 0 0 0 0 0 0
    9 Other Working Capital 4208300000 3882100000 2211000000 2001400000 1755000000 1707099000 2189289000 1604428000 1135511000 711045000 508041000 288194000 192683000 167645000 195019000 176448000 192161000 176448000 192161000 176448000 192161000 176448000 192161000 176448000 192161000 176448000 192161000 176448000 192161000 176448000 192161000 256660000 204653000 293465000 354757000 172902000 29000000 35700000 20600000
    10 Other Non-Cash Items 63500000 -91100000 179100000 30100000 46000000 60299000 42341000 4138000 7430000 6916000 0 165000 476000 21650000 21154000 0 4300000 0 4300000 0 4300000 0 4300000 0 4300000 0 4300000 0 4300000 0 4300000 0 0 0 0 0 100000 -100000 200000
    11 Net Cash Provided by Operating Activities 3002900000 2084900000 426000000 1115600000 1086000000 675199000 640075000 497349000 410613000 270084000 160906000 113841000 53199000 -139614000 -109914000 -96883000 -50400000 -96883000 -50400000 -96883000 -50400000 -96883000 -50400000 -96883000 -50400000 -96883000 -50400000 -96883000 -50400000 -96883000 -50400000 -71993000 -89196000 -46221000 -23172000 -15758000 -7700000 -8000000 -5700000
    12 Investments in PP&E -106700000 -154700000 -213000000 -357300000 -333000000 -286335000 -136650000 -29329000 -21846000 -21982000 -12823000 -35275000 -39733000 -68825000 -31856000 -2980000 -444000 -2980000 -444000 -2980000 -444000 -2980000 -444000 -2980000 -444000 -2980000 -444000 -2980000 -444000 -2980000 -444000 -3135000 -3070000 -4096000 -7021000 -2229000 -1900000 -2100000 -700000
    13 Acquisitions (Net) -2112000000 0 0 0 0 -3939000000 0 0 -606000000 -106000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
    14 Purchase of Investments -77200000 -171100000 -805100000 -1658700000 -675000000 -534703000 -705159000 -1049414000 0 0 -129860000 -19026000 -206778000 -48719000 -734567000 -508818000 -419086000 -508818000 -419086000 -508818000 -419086000 -508818000 -419086000 -508818000 -419086000 -508818000 -419086000 -508818000 -419086000 -508818000 -419086000 -168952000 -114116000 -533117000 -561940000 -78597000 0 0 0
    15 Sales/Maturities of Investments 196300000 236900000 1485800000 1097600000 722000000 1169698000 619447000 60917000 0 94458000 53387000 0 216146000 87985000 853924000 513423000 398971000 513423000 398971000 513423000 398971000 513423000 398971000 513423000 398971000 513423000 398971000 513423000 398971000 513423000 398971000 205242000 183534000 495190000 425117000 0 1900000 0 3100000
    16 Other Investing Activities 0 -100000 2800000 100000 -1000000 5474000 -507000 -9315000 -4000 -307000 -2000 618000 339000 32636000 -33594000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -5000 -37000 -36000 -529000 -40000 0 100000 -100000
    17 Net Cash used for Investing Activities -2099500000 9700000 470500000 -918300000 -287000000 -3585173000 -222869000 -1027141000 -627585000 -33717000 -89318000 -81423000 -38650000 3077000 53907000 1625000 -20600000 1625000 -20600000 1625000 -20600000 1625000 -20600000 1625000 -20600000 1625000 -20600000 1625000 -20600000 1625000 -20600000 33150000 66311000 -41719000 -144373000 -80866000 0 -2000000 2300000
    18 Debt Repayment -130600000 -348000000 -293800000 -175000000 -375000000 -301250000 -55500000 -36000000 -206000000 -60731000 -649000 -44351000 -585000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
    19 Common Stock Issued 0 0 0 0 0 0 0 0 462212000 35765000 37546000 30733000 28893000 47005000 153827000 3743000 67991000 3743000 67991000 3743000 67991000 3743000 67991000 3743000 67991000 3743000 67991000 3743000 67991000 3743000 67991000 127223000 155000 326000 210902000 48116000 400000 25200000 10800000
    20 Common Stock Repurchased -510800000 -416000000 -85000000 -463600000 -430000000 -327699000 -302599000 -66136000 -11553000 0 0 0 0 0 -279000 0 68000000 0 68000000 0 68000000 0 68000000 0 68000000 0 68000000 0 68000000 0 68000000 0 0 0 0 0 0 0 0
    21 Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
    22 Other Financing Activities -29200000 -5000000 -20900000 -43900000 -68000000 -167956000 250875000 102494000 279000 4016000 1970000 -652000 0 0 0 -4758000 0 -4758000 0 -4758000 0 -4758000 0 -4758000 0 -4758000 0 -4758000 0 -4758000 0 0 0 0 342000 527000 500000 -1500000 100000
    23 Net Cash Used Provided by Financing Activities -611900000 -739100000 -102400000 -596600000 -836000000 2985077000 7126000 71639000 666376000 39050000 38867000 -14270000 28308000 64844000 179324000 28985000 67600000 28985000 67600000 28985000 67600000 28985000 67600000 28985000 67600000 28985000 67600000 28985000 67600000 28985000 67600000 127223000 155000 326000 210875000 164244000 500000 24800000 10600000
    24 Net Change in Cash 311000000 1356300000 782900000 -381600000 -44000000 66112000 414142000 -459644000 448636000 273720000 109973000 19160000 42691000 -71505000 123197000 -66273000 -3300000 -66273000 -3300000 -66273000 -3300000 -66273000 -3300000 -66273000 -3300000 -66273000 -3300000 -66273000 -3300000 -66273000 -3300000 88380000 -22730000 -87614000 43330000 67620000 -7300000 14800000 7200000
  • About
    Industry: Biotechnology
    Sector: Healthcare
    Country: US
    IPO Date: 2/1/1996
    Stonk Exchange: NASDAQ
    • Alexion Pharmaceuticals, Inc
    • is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.
    • The company is headquartered in Boston, Massachusetts and currently employs 2,656 full-time employees.
    • The firm is focused on the development and commercialization of therapeutic products.
    • The firm's products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa).
    • The firm's clinical development programs include Soliris (eculizumab), cPMP (ALXN1101), SBC-103, ALXN1210 (IV) and ALXN1210 (Subcutaneous).
    • Its Soliris is the therapeutic approved for patients with either paroxysmal nocturnal hemoglobinuria (PNH) or hemolytic uremic syndrome (aHUS).
    • PNH and aHUS result from chronic uncontrolled activation of the complement component of the immune system.
    • Its Strensiq is for the treatment of patients with Hypophosphatasia (HPP).
    • Its product, Kanuma is for the treatment of patients with Lysosomal Acid Lipase Deficiency (LAL-D).
    • The company is a recombinant form of the human LAL enzyme, which is a replacement therapy that is approved for the treatment for patients with LAL-D.